"Educational Intervention for Tokophobia in Pregnant Women" (TOKO-EDU)
Changes in Tokophobia Awareness, Fear of Childbirth, Coping Strategies, and Quality of Life Following Structured Educational Sessions Among Pregnant Women: A Quasi-Experimental Single-Group Pretest-Posttest Study
This quasi-experimental single-group pretest-posttest study examined immediate within-participant differences in tokophobia awareness, fear of childbirth, reported coping-strategy use, and quality of life among 50 pregnant women attending the antenatal outpatient clinics of Soad Kafafi Hospital, 6th of October City, Giza, Egypt.
Participants attended a standardized program comprising ten face-to-face sessions delivered twice weekly over five weeks. Each session lasted approximately 45-60 minutes, including orientation, baseline assessment, educational activities, review, and post-intervention evaluation.
Outcomes were assessed using the researcher-developed Tokophobia Awareness Questionnaire (TAQ), an Arabic translation of the Fear of Childbirth Questionnaire (FCQ), the Jalowiec Coping Scale (JCS), and WHOQOL-BREF. Baseline measures were completed before educational content was delivered. Post-intervention assessment took place immediately after the final session on the same day. No longer-term follow-up was conducted.
The absence of a comparison group prevents causal attribution of the observed differences to the educational sessions.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The study used a quasi-experimental single-group pretest-posttest design. Fifty pregnant women participated in the main study. Five separate women participated in pilot testing and were excluded from the main-study sample and analysis.
The main-study participants were divided into ten groups of five. The same educator, specializing in obstetric and gynecological health nursing, delivered the standardized program separately to each group. Other research-team members administered and collected the outcome questionnaires.
Each participant attended ten sessions over five consecutive weeks, with two sessions per week and approximately 45-60 minutes per session. Session 1 covered study orientation and procedures. Session 2 included baseline assessment, completed before delivery of educational content. Sessions 3-8 addressed tokophobia-related knowledge, childbirth preparation, coping strategies, stress management, communication, and professional and social support. Session 9 covered review and reinforcement. Session 10 included final reinforcement and immediate post-intervention assessment.
The TAQ assessed factual knowledge and awareness of tokophobia. The FCQ assessed self-reported fear of childbirth rather than establishing a clinical diagnosis of tokophobia. The JCS assessed frequency of coping-strategy use, and WHOQOL-BREF assessed self-reported quality of life across four domains.
No single primary outcome was prospectively designated. The continuous FCQ total score was prioritized for interpretation during manuscript revision. Analyses are exploratory because the study lacked a comparison group and multiple tests were conducted without adjustment.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Giza Governorate
-
Cairo, Giza Governorate, Egypt, 12566
- Soad Kafafi Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women aged 18 years or older.
- Attending the antenatal outpatient clinics at the study setting.
- Willing to participate and provide informed consent.
Exclusion Criteria:
- Diagnosed severe or acute psychiatric disorders that could interfere with study participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Educational Intervention Group
Pregnant women attended a standardized ten-session educational program delivered face-to-face in groups of five, twice weekly over five weeks. Each session lasted approximately 45-60 minutes, including orientation, assessment, educational activities, review, and evaluation. Educational content addressed tokophobia awareness, childbirth preparation, coping strategies, relaxation, stress management, and available professional and social support. |
A structured educational program designed to provide information about tokophobia, its causes, symptoms, and management, along with training on psychological coping strategies and supportive techniques to enhance maternal well-being.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fear of Childbirth Questionnaire (FCQ) Total Score
Time Frame: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the 20-item FCQ total score from baseline to immediate post-intervention assessment. Items are scored 0-3, with positively worded items reverse-scored. Total scores range from 0 to 60; higher scores indicate greater fear of childbirth. The Arabic translation used in this study underwent preliminary linguistic and cultural adaptation. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tokophobia Awareness Questionnaire (TAQ) Total Score
Time Frame: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the researcher-developed 23-item TAQ total score from baseline to immediate post-intervention assessment. Correct responses are scored 1 and incorrect responses 0. Total scores range from 0 to 23; higher scores indicate greater factual knowledge and awareness of tokophobia. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
|
Change in Jalowiec Coping Scale (JCS) Total Score
Time Frame: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Change in the 40-item JCS total score from baseline to immediate post-intervention assessment. Items are scored from 1 to 5, producing total scores ranging from 40 to 200. Higher scores indicate more frequent self-reported coping-strategy use. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
|
Change in WHOQOL-BREF Domain Scores
Time Frame: Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Changes from baseline to immediate post-intervention assessment in the four WHOQOL-BREF domains: physical health, psychological health, social relationships, and environment. Each domain score is transformed to a 0-100 scale, with higher scores indicating better self-reported quality of life. The four domains are analyzed separately. |
Baseline (Session 2, before educational content) and immediately after Session 10, at the end of the five-week program.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Basma W Elrefay, phd, Delta University for Science and Technology, Egypt
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DU-TOKO-2025-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Individual participant data (IPD) will not be made publicly available due to privacy, confidentiality, and ethical restrictions related to the study participants.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.